Here begins the text.

The 2nd Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes

Press Release

When clicking with the mouse or pressing the tab key, Press Release is displayed.

Monday, October 4, 2021   14:00-15:45
* Given the impact of COVID-19, the conference was held online.

Agenda / List of Handouts

  1. Lecture by Subcommittee Member and Discussion
    • Drug Discovery Based on the Murine POC (An Example Using Cytotoxic T Lymphocyte EVs) (Special Lecturer SEO, Member of the Subcommittee)
    • Possibilities and Problems of Engineered Exosomes (Professor HANAYAMA, Vice Chairperson of the Subcommittee)
  2. Issues and Assignment Table of Report on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes
  3. Others

List of Handouts

Confidentiality Classification of Handouts
Document 1 Lecture Material by Special Lecturer SEO (Member of the Subcommittee)
Document 2 Lecture Material by Professor HANAYAMA (Vice Chairperson of the Subcommittee)
Document 3 Lecture Material by Professor TAKAKURA (Chairperson of the Subcommittee)
Reference Document 1 Member List of the Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes
Reference Document 2 Letter to the Editor Published in British Journal of Clinical Pharmacology
https://doi.org/10.1111/bcp.15065 

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

000048771
0
The 2nd Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes
/english/rs-sb-std/sb/subcommittees/0019.html
en